The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression

INTRODUCTION: Metformin has shown good efficacy in the management of antipsychotic-induced metabolic syndrome (MetS) in patients with schizophrenia or schizoaffective disorders. Its ability to induce antidepressant behavioural effects and improve cognitive functions has also been investigated: yet i...

Descripción completa

Detalles Bibliográficos
Autores principales: Battini, Vera, Cirnigliaro, Giovanna, Leuzzi, Rodolfo, Rissotto, Eleonora, Mosini, Giulia, Benatti, Beatrice, Pozzi, Marco, Nobile, Maria, Radice, Sonia, Carnovale, Carla, Dell’Osso, Bernardo, Clementi, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370497/
https://www.ncbi.nlm.nih.gov/pubmed/37502816
http://dx.doi.org/10.3389/fpsyt.2023.1215807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370497/
https://www.ncbi.nlm.nih.gov/pubmed/37502816
http://dx.doi.org/10.3389/fpsyt.2023.1215807

Ejemplares similares